Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients

BACKGROUND: A substantial proportion of critically ill COVID-19 patients develop thromboembolic complications, but it is unclear whether higher doses of thromboprophylaxis are associated with lower mortality rates. The purpose of the study was to evaluate the association between initial dosing strat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Crit Care
Hlavní autoři: Jonmarker, Sandra, Hollenberg, Jacob, Dahlberg, Martin, Stackelberg, Otto, Litorell, Jacob, Everhov, Åsa H., Järnbert-Pettersson, Hans, Söderberg, Mårten, Grip, Jonathan, Schandl, Anna, Günther, Mattias, Cronhjort, Maria
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7680989/
https://ncbi.nlm.nih.gov/pubmed/33225952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-03375-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky